Birdwatch Note
2023-04-18 21:51:09 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This tweet from the FDA is part of a longer thread. They are now recommending a bivalent version of the Moderna and Pfizer vaccines, instead of the monovalent version. https://twitter.com/us_fda/status/1648315662559748096?s=46&t=NIpmcfyBLQrYoT6LRS_gCQ
Written by 97B6D8284B93A22BD817185FF8308A7350A997E0ADAD53302F868063C07AE41C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1648430904732418050
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1648444076252069893
- noteId - 1648444076252069893
- participantId -
- noteAuthorParticipantId - 97B6D8284B93A22BD817185FF8308A7350A997E0ADAD53302F868063C07AE41C Participant Details
- createdAtMillis - 1681854669049
- tweetId - 1648430904732418050
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This tweet from the FDA is part of a longer thread. They are now recommending a bivalent version of the Moderna and Pfizer vaccines, instead of the monovalent version. https://twitter.com/us_fda/status/1648315662559748096?s=46&t=NIpmcfyBLQrYoT6LRS_gCQ
Note Ratings
rated at | rated by | |
2023-04-20 15:04:19 -0500 | Rating Details | |
2023-04-18 19:08:50 -0500 | Rating Details | |
2023-04-18 21:06:51 -0500 | Rating Details | |
2023-04-18 16:56:54 -0500 | Rating Details | |
2023-04-18 17:37:47 -0500 | Rating Details | |
2023-04-18 21:00:50 -0500 | Rating Details | |
2023-04-18 18:39:35 -0500 | Rating Details | |
2023-04-18 17:26:12 -0500 | Rating Details | |
2023-04-18 17:07:56 -0500 | Rating Details | |
2023-04-18 21:24:41 -0500 | Rating Details | |
2023-04-19 06:47:41 -0500 | Rating Details | |
2023-04-18 21:44:35 -0500 | Rating Details | |
2023-04-18 17:44:28 -0500 | Rating Details | |
2023-04-19 08:32:24 -0500 | Rating Details | |
2023-04-18 17:12:25 -0500 | Rating Details | |
2023-04-19 14:30:36 -0500 | Rating Details | |
2023-04-18 17:50:56 -0500 | Rating Details | |
2023-04-18 16:54:35 -0500 | Rating Details | |
2023-04-18 18:17:52 -0500 | Rating Details | |
2023-04-18 20:20:38 -0500 | Rating Details | |
2023-04-18 18:21:36 -0500 | Rating Details | |
2023-04-18 18:25:58 -0500 | Rating Details | |
2023-04-18 17:39:18 -0500 | Rating Details | |
2023-04-18 17:15:12 -0500 | Rating Details | |
2023-04-18 17:23:20 -0500 | Rating Details | |
2023-04-18 20:11:25 -0500 | Rating Details | |
2023-04-18 18:55:53 -0500 | Rating Details | |
2023-04-18 17:01:50 -0500 | Rating Details | |
2023-04-18 19:44:46 -0500 | Rating Details | |
2023-04-18 18:17:29 -0500 | Rating Details | |
2023-04-18 17:27:07 -0500 | Rating Details | |
2023-04-18 19:56:16 -0500 | Rating Details | |
2023-04-19 06:31:35 -0500 | Rating Details | |
2023-04-18 17:01:14 -0500 | Rating Details | |
2023-04-18 18:50:06 -0500 | Rating Details | |
2023-04-18 17:01:01 -0500 | Rating Details | |
2023-04-18 17:05:01 -0500 | Rating Details | |
2023-04-18 17:03:50 -0500 | Rating Details | |
2023-04-18 18:18:59 -0500 | Rating Details | |
2023-04-20 15:04:19 -0500 | Rating Details | |
2023-04-18 19:08:50 -0500 | Rating Details | |
2023-04-18 21:06:51 -0500 | Rating Details | |
2023-04-18 16:56:54 -0500 | Rating Details | |
2023-04-18 17:37:47 -0500 | Rating Details | |
2023-04-18 21:00:50 -0500 | Rating Details | |
2023-04-18 18:39:35 -0500 | Rating Details | |
2023-04-18 17:26:12 -0500 | Rating Details | |
2023-04-18 17:07:56 -0500 | Rating Details | |
2023-04-18 21:24:41 -0500 | Rating Details | |
2023-04-19 06:47:41 -0500 | Rating Details | |
2023-04-18 21:44:35 -0500 | Rating Details | |
2023-04-18 17:44:28 -0500 | Rating Details | |
2023-04-19 08:32:24 -0500 | Rating Details | |
2023-04-18 17:12:25 -0500 | Rating Details | |
2023-04-19 14:30:36 -0500 | Rating Details | |
2023-04-18 17:50:56 -0500 | Rating Details | |
2023-04-18 16:54:35 -0500 | Rating Details | |
2023-04-18 18:17:52 -0500 | Rating Details | |
2023-04-18 20:20:38 -0500 | Rating Details | |
2023-04-18 18:21:36 -0500 | Rating Details | |
2023-04-18 18:25:58 -0500 | Rating Details | |
2023-04-18 17:39:18 -0500 | Rating Details | |
2023-04-18 17:15:12 -0500 | Rating Details | |
2023-04-18 17:23:20 -0500 | Rating Details | |
2023-04-18 20:11:25 -0500 | Rating Details | |
2023-04-18 18:55:53 -0500 | Rating Details | |
2023-04-18 17:01:50 -0500 | Rating Details | |
2023-04-18 19:44:46 -0500 | Rating Details | |
2023-04-18 18:17:29 -0500 | Rating Details | |
2023-04-18 17:27:07 -0500 | Rating Details | |
2023-04-18 19:56:16 -0500 | Rating Details | |
2023-04-19 06:31:35 -0500 | Rating Details | |
2023-04-18 17:01:14 -0500 | Rating Details | |
2023-04-18 18:50:06 -0500 | Rating Details | |
2023-04-18 17:01:01 -0500 | Rating Details | |
2023-04-18 17:05:01 -0500 | Rating Details | |
2023-04-18 17:03:50 -0500 | Rating Details | |
2023-04-18 18:18:59 -0500 | Rating Details |